Learning Objectives:


  • Review the symptoms of RSV and its impact on infants and neonates
  • Understand the structure of the RSV pathogen and the mechanism of the nirsevimab monoclonal antibody
  • Discuss the history of vaccine technology against the RSV vaccine
  • Review the results of a large randomized control trial examining the use of the Abrysvo vaccine in pregnant women
  • Provide discussion points for anticipated questions from patients regarding this vaccine to aid in antenatal counseling




Session date: 
10/11/2023 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Matthew Pellerite, MD and Luke Burns, MD